Home ›
Entities
› academia
› Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Research article (Cancer Discovery, 2019) · cited 433× · AI/ML
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Summary
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia is a scholarly article[1].
Key Facts
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia. Retrieved May 24, 2026, from https://4ort.xyz/entity/clonal-selection-with-ras-pathway-activation-mediates-secondary-clinical-resistance-to-selective-flt3-inhibition-in-acut
MLA“Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/clonal-selection-with-ras-pathway-activation-mediates-secondary-clinical-resistance-to-selective-flt3-inhibition-in-acut.
BibTeX@misc{4ortxyz_clonal-selection-with-ras-pathway-activation-mediates-secondary-clinical-resistance-to-selective-flt3-inhibition-in-acut_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia}}, year = {2026}, url = {https://4ort.xyz/entity/clonal-selection-with-ras-pathway-activation-mediates-secondary-clinical-resistance-to-selective-flt3-inhibition-in-acut}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia — https://4ort.xyz/entity/clonal-selection-with-ras-pathway-activation-mediates-secondary-clinical-resistance-to-selective-flt3-inhibition-in-acut (retrieved 2026-05-24)
